This was followed by parallel programs to develop RNA therapeutics to alter exon selection during processing of the dystrophin (DMD) pre-mRNA and generate internally truncated but functional dystrophin isoforms that reflect variants found in the less severe allelic disorder, Becker muscular dystrophy (for review, see13). Here, DMD is linked to Duchenne muscular dystrophy.